244 related articles for article (PubMed ID: 9572470)
21. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
Marchetti D
J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
[TBL] [Abstract][Full Text] [Related]
22. Substrate specificity of heparanases from human hepatoma and platelets.
Pikas DS; Li JP; Vlodavsky I; Lindahl U
J Biol Chem; 1998 Jul; 273(30):18770-7. PubMed ID: 9668050
[TBL] [Abstract][Full Text] [Related]
23. [Human heparanase: roles in invasion and metastasis of cancer].
Gohji K; Katsuoka Y; Okamoto M; Kamidono S; Kitazawa S; Toyoshima M; Dong J; Nakajima M
Hinyokika Kiyo; 2000 Oct; 46(10):757-62. PubMed ID: 11215206
[TBL] [Abstract][Full Text] [Related]
24. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
Benezra M; Vlodavsky I; Bar-Shavit R
Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
[TBL] [Abstract][Full Text] [Related]
25. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
26. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.
Vlodavsky I; Friedmann Y; Elkin M; Aingorn H; Atzmon R; Ishai-Michaeli R; Bitan M; Pappo O; Peretz T; Michal I; Spector L; Pecker I
Nat Med; 1999 Jul; 5(7):793-802. PubMed ID: 10395325
[TBL] [Abstract][Full Text] [Related]
27. Connective tissue activation XXXVIII: heparin/heparanase activity of human platelets resides in a high molecular weight protein, not in connective tissue activating peptide III.
Castor CW; Kotlyar A; Edwards BE
J Rheumatol; 2002 Nov; 29(11):2337-44. PubMed ID: 12415589
[TBL] [Abstract][Full Text] [Related]
28. Multiple heparanases are expressed in polymorphonuclear cells.
Kosir MA; Foley-Loudon PA; Finkenauer R; Tennenberg SD
J Surg Res; 2002 Mar; 103(1):100-8. PubMed ID: 11855924
[TBL] [Abstract][Full Text] [Related]
29. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
[TBL] [Abstract][Full Text] [Related]
30. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
31. Heparanase processing by lysosomal/endosomal protein preparation.
Cohen E; Atzmon R; Vlodavsky I; Ilan N
FEBS Lett; 2005 Apr; 579(11):2334-8. PubMed ID: 15848168
[TBL] [Abstract][Full Text] [Related]
32. Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.
Sanderson RD; Yang Y; Suva LJ; Kelly T
Matrix Biol; 2004 Oct; 23(6):341-52. PubMed ID: 15533755
[TBL] [Abstract][Full Text] [Related]
33. A cellulose-binding domain-fused recombinant human T cell connective tissue-activating peptide-III manifests heparanase activity.
Rechter M; Lider O; Cahalon L; Baharav E; Dekel M; Seigel D; Vlodavsky I; Aingorn H; Cohen IR; Shoseyov O
Biochem Biophys Res Commun; 1999 Feb; 255(3):657-62. PubMed ID: 10049766
[TBL] [Abstract][Full Text] [Related]
34. Heparanase upregulation in high glucose-treated endothelial cells is prevented by insulin and heparin.
Han J; Woytowich AE; Mandal AK; Hiebert LM
Exp Biol Med (Maywood); 2007 Jul; 232(7):927-34. PubMed ID: 17609509
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of activation of human heparanase investigated by protein engineering.
Nardella C; Lahm A; Pallaoro M; Brunetti M; Vannini A; Steinkühler C
Biochemistry; 2004 Feb; 43(7):1862-73. PubMed ID: 14967027
[TBL] [Abstract][Full Text] [Related]
36. Heparanase expression in invasive trophoblasts and acute vascular damage.
Dempsey LA; Plummer TB; Coombes SL; Platt JL
Glycobiology; 2000 May; 10(5):467-75. PubMed ID: 10764835
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase.
Levy-Adam F; Abboud-Jarrous G; Guerrini M; Beccati D; Vlodavsky I; Ilan N
J Biol Chem; 2005 May; 280(21):20457-66. PubMed ID: 15760902
[TBL] [Abstract][Full Text] [Related]
38. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
Vlodavsky I; Elkin M; Pappo O; Aingorn H; Atzmon R; Ishai-Michaeli R; Aviv A; Pecker I; Friedmann Y
Isr Med Assoc J; 2000 Jul; 2 Suppl():37-45. PubMed ID: 10909416
[TBL] [Abstract][Full Text] [Related]
39. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
40. Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.
Tumova S; Hatch BA; Law DJ; Bame KJ
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):471-81. PubMed ID: 9895290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]